CarieScan names new director of operations
This article was originally published in Clinica
Executive Summary
CarieScan, a company that produces handheld devices to detect tooth decay, has appointed Bill Lees director of operations. Mr Lees, who will be responsible for the company's manufacturing, R&D, and quality and regulatory processes, has over 10 years of experience in similar positions. The firm's lead product, the CarieScan Pro, detects early-stage caries, or cavities. It is CE marked for sale in Europe and has US FDA 510(k) clearance. Dundee, UK-based CarieScan, a subsidiary of 3D Diagnostic Imaging, is currently working towards its first US distribution deal for the product.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.